Gubra A/S - Asset Resilience Ratio

Latest as of December 2025: 79.61%

Gubra A/S (GUBRA) has an Asset Resilience Ratio of 79.61% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Gubra A/S short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

Dkr1.05 Billion

≈ $164.40 Million USD Cash + Short-term Investments

Total Assets

Dkr1.32 Billion

≈ $206.50 Million USD All company assets

Resilience Assessment

Very High

Financial Resilience Level

Asset Resilience Ratio Trend (2023–2025)

This chart shows how Gubra A/S's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see Gubra A/S asset portfolio.

Liquid Assets Composition Over Time

This chart breaks down Gubra A/S's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Read Gubra A/S (GUBRA) financial obligations for a breakdown of total debt and financial obligations.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	Dkr0.00	0%
Short-term Investments	Dkr1.05 Billion	79.61%
Total Liquid Assets	Dkr1.05 Billion	79.61%

Asset Resilience Insights

Very High Liquidity: Gubra A/S maintains exceptional liquid asset reserves at 79.61% of total assets.
This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
The company has significant short-term investments, indicating active treasury management.

Gubra A/S Industry Peers by Asset Resilience Ratio

Compare Gubra A/S's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Abivax SA PA:ABVX	Biotechnology	2.58%
Shanghai RAAS Blood Products Co Ltd Class A SHE:002252	Biotechnology	2.03%
Neuren Pharmaceuticals Ltd AU:NEU	Biotechnology	90.43%
Lifecome Biochemistry Co Ltd SHE:002868	Biotechnology	4.69%
Pulike Biological Engineering SHG:603566	Biotechnology	17.82%
Rocket Pharmaceuticals Inc NASDAQ:RCKT	Biotechnology	14.00%
NEWRON PHARMACEUT. EO-20 XETRA:NP5	Biotechnology	41.67%
Upstream Bio, Inc. NASDAQ:UPB	Biotechnology	64.70%

Annual Asset Resilience Ratio for Gubra A/S (2023–2025)

The table below shows the annual Asset Resilience Ratio data for Gubra A/S.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	79.61%	Dkr1.05 Billion ≈ $164.40 Million	Dkr1.32 Billion ≈ $206.50 Million	+32.62pp
2024-12-31	47.00%	Dkr287.84 Million ≈ $45.03 Million	Dkr612.48 Million ≈ $95.83 Million	-17.61pp
2023-12-31	64.61%	Dkr403.99 Million ≈ $63.21 Million	Dkr625.28 Million ≈ $97.83 Million	--

pp = percentage points

About Gubra A/S

CO:GUBRA Denmark Biotechnology

Market Cap

$777.87 Million

Dkr4.97 Billion DKK

Market Cap Rank

#10186 Global

#51 in Denmark

Share Price

Dkr304.40

Change (1 day)

-1.23%

52-Week Range

Dkr290.20 - Dkr534.00

All Time High

Dkr728.00